Systematic Review with Meta-Analysis: Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C Genotypes 5 and 6

Figure 4

Funnel plot of pooling SVR12 of DAA regimens on HCV genotype 6. SVR12, sustained virological response rates at 12 weeks; HCV, hepatitis C virus; DAA, direct-acting antiviral.